Lymphoid interstitial pneumonitis (LIP),
Pulmonary lymphoid infiltrates range from pulmonary lymphoid hyperplasia (PLH), lymphoid interstitial pneumonitis (LIP), polyclonal polymorphic B-cell lymphoproliferative disorder, and malignant lymphoma (1) . LIP is a common pulmonary complication in pediatric AIDS patients, present in Յ75% of cases (2, 3) . Recently, a spectrum of mucosa-associated lymphoid tissue (MALT) lesions (4), multilocular thymic cysts associated with LIP (5-8) and a spectrum of pulmonary lymphoid infiltrates have been described in pediatric HIVinfected patients (1) .
Malignant lymphoma of mucosa-associated lymphoid tissue (MALT) is a low-grade B-cell lymphoma with a predilection for mucosa-associated sites such as the stomach, lung, salivary gland, lac-rimal glands, thyroid, skin, and thymus. These tumors are localized and have a low risk of dissemination to bone marrow and lymph nodes (9 -12) . MALT lymphoma is preceded by inflammatory reactive lymphoid tissues such as those seen in Sjogren's syndrome, Hashimoto's thyroiditis, and Helicobacter pylori gastritis (13) .
We previously reported two cases of pulmonary marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue (ML-MALT) associated with LIP (14 -15) . Histologically, LIP shows a diffuse peribronchial and interstitial lymphoid infiltrate in the pulmonary parenchyma with polyclonal plasma cells. The etiology and pathogenesis is not known. It has been postulated that bronchus-associated lymphoid tissue and LIP may represent a premalignant organ response to an antigenic stimulus (16) that may progress to MALT lymphoma. In addition, immune dysregulation is thought to be involved in the pathogenesis of LIP, which can be seen also in adults with autoimmune disease (2, 8, 17, 18) .
Recently, increased cytokine gene expression, including interferon-␥ (IFN-␥), interleukin-10 (IL-10), transforming growth factor-␤ (TGF-␤), and interleukin-1 (IL-1) was described in a murine model of AIDS (MAIDS)-associated interstitial pneumonitis (19, 20) . The model for development of MAIDS-associated interstitial pneumonitis proposed that infection with LP-BM5 retrovirus leads to an inappropriate cellular interaction between T and B cells, which polyclonally activate a large fraction of T cells in the infected animal. Inappropriate interactions between Th1 T cells and antigenpresenting B cells induce chronic interferongamma production that causes chronic macrophage activation and ultimate sustained inflammation and tissue remodeling of the lung (19, 20) . We wished to determine whether cytokine and chemokine gene expression play a role in the recruitment of inflammatory cell infiltrates into LIP tissues and whether the presence of activated lymphoid cells may contribute to the evolution of a clonal B-cell population, indicating a clonal relationship between pulmonary LIP and MALT lymphoma in pediatric HIV-infected patients.
MATERIALS AND METHODS

Case Selection
Patient cases were retrieved from the files of the Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Criteria for study inclusion included the following: 1) the patient being HIV positive and Ͻ18 years of age; 2) the patient having a diagnosis of pulmonary LIP and/or malignant lymphoma of MALT; and 3) the availability of paraffin or frozen-tissue blocks for immunohistochemical studies, immunoglobulin heavy-chain gene rearrangement analysis by polymerase chain reaction (PCR), and chemokine/cytokine gene expression by reverse-transcription-mediated polymerase chain reaction (RT-PCR). The study population was comprised of six patients total, including 3 females and 3 males, ranging in age from 2-15 years of age at the time of the diagnostic biopsy. Of the six patients, four were diagnosed with LIP, one with pulmonary MALT lymphoma, and one with concurrent LIP and MALT lymphoma. Five patients had vertically acquired HIV, and one patient was infected after blood transfusion (Table 1) .
Immunohistochemistry
Staining was performed after antigen retrieval using 50 mM TRIS buffer, pH 7.4, and microwaving for 10 minutes at 700W. Staining was performed without enzyme digestion on an automated immunostainer (Ventana Medical Systems, Inc., Tucson, AZ). A panel of monoclonal antibodies was used: CD20 (L26) and CD3 (DAKO, Carpinteria, CA); CD43 (Leu 22, Beckton Dickinson, San Jose, CA); and antikappa and anti-lambda (Biosource, Burlingame, CA; Table 2 ).
Epstein-Barr Virus In Situ Hybridization
In situ hybridization used an Epstein-Barr virus (EBV) probe specific for EBV-encoded small RNAs (EBER), as described previously (21), using an automated system (Ventana). (21) , and products were analyzed by polyacrylamide gel electrophoresis (PAGE). PCR was also performed to detect HHV-8 viral sequences using primers (HHV-8 1-5:5'-TAGCCCAAAGGATTCCA-CCAT-3' and HHV-8 1-3:5'-GGATCCGTGTTGTC-TACGTC-3') and conditions as previously published (22) , and products were analyzed on agarose gels. The MALT lymphoma from Case 2 was also studied by Southern blot hybridization (14) .
Reverse Transcriptase-Mediated PCR
RNA extraction from paraffin-embedded tissue was performed as previously described with modifications (23) . Briefly, six to ten 20-m paraffin sections were deparaffinized three times in xylene (with heating at 55°C for 10 min), twice in 100% ethanol and twice in 70% ethanol. Sections were resuspended in 1 mL extraction buffer (10 mM NaCl, 50 mM Tris-HCL, pH 7.4, 20 mM EDTA, 1% SDS) at 55°C overnight with 500 g/uL of proteinase K. After addition of 1 mL of RNA Trizol (Gibco/BRL, Life Technologies, Gaithersburg, MD) and 200 L of chloroform, followed by centrifugation, the aqueous phase was combined with an equal volume of isopropanol. The precipitated pellet was washed with 70% ethanol and resuspended in diethylpyrocarbonate-treated water.
RT-PCR was performed as previously described with modifications for highly degraded RNA obtained from paraffin-embedded tissues (23) . For semiquantitative results, PCR products were detected by quantitating incorporated 32 P (␣-dCTP) radioactivity. The amount of each RNA sample used was selected on the basis of equivalent amounts of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA amplified from each sample. Variability of results from different experiments was minimized by use of a standard control RNA preparation from cultured IFN-␥ stimulated endothelial cells. RNA samples were DNAse treated (GIBCO/BRL, Life Technologies, Gaithersburg, MD), then subjected to an initial assay for amplifiable contaminating genomic DNA using primers specific for G3PDH mRNA. Positive samples were retreated with DNase; negative samples (2-5 g) were reverse transcribed using an RNase H-RT (Superscript; GIBCO/ BRL). The resultant cDNA (25-100 ng) was amplified as previously described with modifications (23). Primers, listed in Table 3 , were designed for amplification of short amplicons (80 -130 bp) from highly degraded RNA, and spanned at least one splice junction. Genomic DNA could be distinguished from mRNA or cDNA. Appropriately sized amplicon products using cell line controls were confirmed using molecular weight markers. Optimum primer-annealing temperatures were chosen using a temperature gradient, and amplifications were performed in a thermocycler (Stratagene Robocycler 96 with the Hot Top Assembly, La Jolla, CA), adding 1.25U Platinum Taq polymerase (Gibco/BRL) after heating at 94°C for 3 minutes ("Hot Start"), followed by 35 amplification cycles (94°C, 45 s; primer annealing temperature as specified in Table 3 , and extension at 72°C). These were then maintained at 4°C until analysis. The entire amplification reaction (50 L) was analyzed by electrophoresis on 8% acrylamide (Long Ranger; AT Biochem, Malvern, PA) Tris-borate EDTA gels (PAGE), followed by autoradiography and quantitation by phosphorimage analysis using ImageQuant Version 3.3 software (Molecular Dynamics). Band integrations were obtained as the sum of values for all pixels above background (areas around each sample). Integrated volumes were then normalized to the standard positive control (IFN-␥-stimulated endothelial cells). Standard-normalized integrated values for each sample were then normalized for the results of RT-PCR amplification for G3PDH. The results of RT-PCR analysis are presented as the geometric means of the absolute numbers of normalized arbitrary units (pixels)/sample for each chemokine and cytokine. 
RESULTS
Tissues involved by LIP and ML-MALT from HIVpositive pediatric patients were analyzed by immunohistochemistry, in situ hybridization for EpsteinBarr virus, PCR for HHV-8, and immunoglobulin heavy-chain gene rearrangement (VDJ-PCR), and RT-PCR for chemokine/cytokine gene expression to evaluate the nature and pathogenesis of the pulmonary lymphoid infiltrates and to examine the clonal relationship of LIP to pulmonary MALT lymphoma in pediatric HIV-positive patients.
Histologically, the pulmonary parenchyma involved by LIP showed a dense lymphoid infiltrate composed of germinal centers with scattered plasma cells and epithelioid histiocytes. Immunohistochemistry studies performed on the LIP biopsies showed an admixture of B (L26, CD20) and T (CD3) lymphocytes with polyclonal cells of B-cell lineage ( Table 2 , Fig. 1 ). The two patients with MALT lymphoma also histologically showed a dense lymphoid infiltrate extensively involving the pulmonary parenchyma. The neoplastic cells surrounded reactive follicles in a marginal zone or parafollicular pattern. The neoplastic cells were small but heterogeneous in morphology composed of small lymphocytic, plasmacytoid, monocytoid, and "centrocyte-like" features. The tumor cells expressed L26 (CD20) and co-expressed Leu 22 (CD43). The plasma cells showed monoclonal lambda light-chain restriction in the two cases of pulmonary MALT lymphoma.
PCR for HHV-8 was negative in five of five biopsies. In situ hybridization for Epstein-Barr virus was performed on two biopsies diagnosed as pulmonary MALT lymphoma and showed rare scattered cells, but overall was interpreted as negative.
Immunoglobulin heavy-chain gene rearrangement (VDJ-PCR) showed a polyclonal ladder in all 5 patients with LIP. In contrast, two patients with pulmonary MALT showed a dominant monoclonal band with a background polyclonal ladder pattern. One of the two cases of pulmonary MALT lymphoma showed immunoglobulin gene rearrangements of both heavy and light chains by Southern blot analysis (14) , and the associated LIP biopsy from this patient showed a band of increased intensity, similar in size to that in the concurrent MALT lymphoma biopsy with a background polyclonal ladder pattern ( Table 2 , Fig. 2) .
RNA was extracted from paraffin-embedded tissues from five lung biopsies in four pediatric HIVpositive patients and from five control, normal lung biopsies in five HIV-negative patients and was analyzed by semiquantitative RT-PCR for the expression of cytokines (TNF-␣, GM-CSF, IFN-␥, IL-4, IL-6, IL-10, and IL-18) and chemokines (IP-10; Mig; regulated upon activation, normal T expressed and secreted [RANTES]; and MIP1-␣ and ␤) after nor- Mig  X72755  TTCCTCTTGGGCATCATCTTGCTG;  123  57  S60728  GGTCTTTCAAGGATTGTAGGTGGA  IP-10  X02530  GGAACCTCCAGTCTCAGCACC;  108  57  M17752  GCGTACGGTTCTAGAGAGAGGTAC  IFN-␥  V00536  GGACCCATATGTAAAAGAAGCAGA;  121  57  AO4665  TGTCACTCTCCTCTTTCCAATTCT  MIP-1␣  M25315  CTCTGCACCATGGCTCTCTGCAAC;  87  62  TGTGGAATCTGCCGGGAGGTGTAG  MIP-1␤  M25316  CTCCTCATGCTAGTAGCTGCCTTC;  90  62  GGTGTAAGAAAAGCAGCAGGCGGT  RANTES  M21121  GGCACGCCTCGCTGTCATCCTCA;  130  65  CTTGATGTGGGCACGGGGCAGTG  TNF-␣  M10988  AGAGGGAAGAGTCCCCCAGGA;  81 Mig, monokine induced by interferon-␥; IP-10, interferon-␥ inducing protein-10; IFN-␥, interferon-gamma; MIP-1␣ and -␤, macrophage inflammatory protein 1-alpha and beta; RANTES, regulated upon activation, normal T expressed and secreted; TNF-␣, tumor necrosis factor-alpha; GM-CSF, granulocyte-macrophage stimulating factor; IL-4, interleukin-4; IL-10, interleukin-10; IL-18, interleukin-18; IL-6, interleukin-6; G3PDH, glyceraldehyde-3-phosphate dehydrogenase. malization for G3PDH (Fig. 3) . Consistent with the detection of IFN-␥ in a murine model of AIDSassociated LIP, IFN-␥ was also present in pediatric LIP tissues. Expression of a newly discovered molecule called IFN-␥-inducing factor or IGIF (now designated IL-18) was increased, as well as that of IFN-␥-inducible CXC chemokines IP-10 and Mig in LIP tissues, compared with controls. RANTES and MIP1-␣ and -␤ were also increased in pediatric LIP lesions compared with controls. In contrast, expression of TNF-␣, GM-CSF, IL-10, and IL-6 was variable in LIP tissues and controls, and IL-4 was not expressed in LIP tissues and controls (Fig. 4) .
DISCUSSION
In this study, we provide evidence of high-level expression of certain chemokines and cytokines in LIP tissues from HIV-infected pediatric patients and suggest that chemokines and cytokines may play an important role in the recruitment of inflammatory cell infiltrates into these tissues. The microenvironment of the inflammatory cells in LIP may activate B cells and contribute to the development of a monoclonal B-cell population. Analogous to Helicobacter pylori lymphocytic chronic gastritis and gastric MALT lymphoma, or myoepithelial sialadenitis and salivary gland MALT lymphoma (24, 25) , LIP may therefore represent an early stage or a precursor lesion of pulmonary MALT lymphoma.
Recently, increased cytokine expression including IFN-␥, IL-10, TGF-␤, and IL-1 was described in a murine model of AIDS-associated interstitial pneumonitis (19, 20) . We also observed IFN-␥ mRNA expression in LIP tissues from pediatric HIVinfected patients that was absent in control normal lung tissues from non-HIV infected patients. However, in addition, we showed increased production of IFN-␥-inducible molecules such as IP-10 and Mig that are chemoattractants for T and NK cells (26, 27) in LIP tissues compared with control normal lung tissues. A newly discovered molecule, called IGIF (now designated IL-18) with potent IFN-␥-inducing activity (28) , was also increased in LIP tissues compared with in normal lung controls, explaining the presence of IFN-␥, IP-10, and Mig. IL-18 is produced by activated T cells (28) and can inhibit IL-10 production (29) . In addition, chemokines related to activated T-cell and macrophage expression such as RANTES and MIP1-␣ and -␤ mRNA levels were increased in LIP tissues com- pared with normal lung tissues. IL-2, IL-4, IL-10, IL-6, and IL-10 have been shown to be essential for B-cell maturation, and therefore, T cells may determine not only the type of B-cell immune response but may also provide key molecules in B-cell lymphoma initiation and progression (30) . IL-6 and IL-10 were variably expressed in LIP tissues and controls and may contribute to the activated B-cell population; however, viral genes such as EBV and HHV-8 did not play a role for B-cell stimulation and growth in these lesions. TNF-␣, GM-CSF, and IL-10 were variably expressed in LIP tissues and may explain the presence of activated macrophages in some of the LIP lesions. IL-4 mRNA was not detected in LIP lesions nor in control tissues. Therefore, we observed increased expression of certain cytokines and chemokines involved in lymphocyte activation and chemotaxis, possibly explaining the lymphoid cell infiltrates seen in pediatric LIP lesions. Similar to the case with the murine AIDS model, inappropriate interactions between Th1 T cells and antigen-presenting B cells may be inducing chronic IFN-␥ production, which causes chronic macrophage activation and ultimate sustained inflammation and tissue remodeling of the lung in pediatric LIP patients.
The presence of activated lymphoid cells may contribute to the evolution of a clonal B-cell population, indicating a clonal relationship between pulmonary LIP and MALT lymphoma in pediatric HIV-infected patients. By VDJ-PCR analysis, we demonstrated that clonal expansion may develop from a polyclonal or oligoclonal process. This was especially evident in the patient with concurrent LIP and pulmonary MALT lymphoma showing a monoclonal band of the same size in both the LIP and MALT lesion, and chemokine and cytokine mRNAs for Mig, IP-10, IFN-␥, RANTES, MIP1-␣ and ␤, Tables 1 and 2) ; C, the patient with concurrent pulmonary MALT lymphoma and LIP; note that the LIP lesion showed a band slightly increased in intensity and of the same size as the monoclonal band amplified from the pulmonary MALT lymphoma lesion.
FIGURE 3.
Patterns of cytokine and chemokine mRNA expression from paraffin-embedded tissues representative of lymphoid interstitial pneumonitis and pulmonary mucosa-associated lymphoid tissue lymphoma from HIV-positive pediatric patients, compared with a representative case of normal lung control tissue from a non-HIV infected patient. Total RNA was extracted and subjected to RT-PCR analysis using appropriately designed primers and conditions after normalization for G3PDH (Table 3) .
and TNF-␣ were present in both the LIP and MALT lesion in this patient, indicating that a microenvironment of activated T cells and macrophages may have contributed to the evolution of a monoclonal B-cell population to evolve.
Finally, we also showed that VDJ-PCR can be diagnostically useful in distinguishing MALT lymphoma from LIP. Surgical excision appears to be adequate treatment for isolated pulmonary MALT lymphoma in this setting. Of the six patients on whom clinical follow-up was available, Patients 1, 2, and 4 (Table 2) are well, off steroids, with no recurrence to date. Patient 6 developed a lymphoproliferative process in the parotid gland, was treated with interferon-␣ and retinoic acid, and is now well, off chemotherapy with no recurrence. 
